Burkitt's acute lymphocytic leukemia (L3ALL) in adults

Hematology/Oncology Clinics of North America

Volumn 15, Issue 1, 2001, Pages 37-50

  Fenaux, Pierre ^a,b   Bourhis, Jean Henri ^b   Ribrag, Vincent ^b  

^a Service des Maladies du Sang   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISOLONE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKULL IRRADIATION; TREATMENT OUTCOME;

EID: 0035096471     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70199-4     Document Type: Article

References (42)

1. Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): Results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol
2. Adolescent and adult acute lymphoblastic leukemia: Prognostic features and outcome of therapy. A study of 293 patients
3. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group
4. Treatment of acute lymphoblastic leukaemia in adults
5. Cytogenetic studies on Burkitt's lymphoma-leukemia
6. Burkitt's lymphoma/leukemia: A clinicopathologic study on 24 adult patients
7. Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemia
8. Acute lymphoblastic leukemia in adults
9. Human C-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt's lymphoma cells
10. Burkitt-like lymphomas in AIDS patients: Characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin's lymphomas. Burkitt's Lymphoma Study Group
11. 3ALL) in adults: A report of eighteen cases
12. Acute leukemia with Burkitt's tumor cells: A study of 6 cases with special reference to lymphocyte surface markers
13. B cell acute lymphocytic leukemia in adults. Clinical, morphologic, and immunologic findings
14. Mature B-cell acute leukemia: A clinical, morphological, immunological, and cytogenetic study of nine cases
15. Improved outcome in adult B-cell acute lymphoblastic leukemia
16. Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia
17. Chromosomal abnormalities in adult non-endemic Burkitt's lymphoma and leukemia: 22 new reports and a review of 148 cases from the literature
18. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986)
19. Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients
20. 3 acute leukemia and advanced-stage Burkitt's lymphoma
21. Acquired immunodeficiency syndrome-related lymphoma
22. Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen
23. Mental neuropathy from systemic cancer
24. B-cell acute lymphoblastic leukaemia: Clinical and biological aspects
25. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine
26. 3 morphology associated with a B-precursor immunophenotype: The Pediatric Oncology Group experience
27. Clinical features and correlates with immunopathology and molecular biology of a large group of patients with AIDS associated small non-cleaved lymphoma (SNCL)
28. Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: Experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults
29. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society
30. The BFM-protocol for HIV-negative Burkitt's lymphomas and L3 ALL in adult patients: A high chance for cure
31. Curability of relapsed childhood B-cell non-Hodgkin's lymphoma after intensive first line therapy: A report from the Societé Francaise d'Oncologie Pediatrique
32. Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: A report of 48 cases
33. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90
34. B-cell acute lymphoblastic leukemia (B-ALL): A report of 17 pediatric cases
35. Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols
36. Burkitt's lymphoma in adults with and without human immunodeficiency virus infection: A single-institution clinicopathologic study of 75 patients
37. Clinical and biological heterogeneity of childhood B cell acute lymphocytic leukemia: Implications for clinical trials
38. Eighty-one percent event-free survival in advanced Burkitt's lymphoma/leukemia: No differences in outcome between pediatric and adult patients treated with the same intensive pediatric protocol
39. Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission
40. Immunological typing of acute lymphoblastic leukaemia
41. Leucémies aiguës lymphoblastiques à cellules de Burkitt. Aspects cliniques, thérapeutiques et évolutifs
42. Effective low-morbidity, outpatient induction therapy for adult acute lymphocytic leukemia (ALL)